KABOOM Sexual Performance Strips Recalled for Undeclared Drug
Blue Square Market recalls KABOOM action strips due to undeclared Sulfoaildenafil. Check your box and stop use immediately.
Stop using this now
Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.
Contact the company
What happened, in plain English
Blue Square Market, Inc. is recalling all lots of KABOOM action strips, also labeled as Sexual Performance Strips, because they are marketed without an approved New Drug Application or Abbreviated New Drug Application. The product contains undeclared Sulfoaildenafil, a drug ingredient that was not disclosed on the label. This recall affects 132 boxes distributed nationwide. Read more at govinfonow.com/recall/43866-blue-square-market-inc-recalls-kaboom-action-strips-sexual-performance.
Source Summary by GovInfoNow · govinfonow.com/recall/43866-blue-square-market-inc-recalls-kaboom-action-strips-sexual-performance · Updated October 12, 2026 · FDA enforcement record: FDA #D-0297-2016
Cite this page
“KABOOM Sexual Performance Strips Recalled for Undeclared Drug.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43866-blue-square-market-inc-recalls-kaboom-action-strips-sexual-performance. Based on FDA recall #D-0297-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0297-2016%22&limit=1).
Why it’s dangerous
The product contains Sulfoaildenafil, a drug component that was not declared on the packaging. Because the product is marketed without FDA approval, the safety and dosage of this undeclared ingredient are unknown, posing potential health risks to users.
Who’s affected
Consumers who purchased KABOOM action strips or Sexual Performance Strips packaged in 6.4oz boxes containing 12 strips per box. Individuals using these products for sexual performance are at risk of ingesting an undeclared pharmaceutical ingredient.
How to tell if you have this one
Look for KABOOM action strips or Sexual Performance Strips in a 6.4oz box containing 12 strips per box. The manufacturer is Nutrology USA LLC, distributed by Blue Square Market, Inc. All lots are included in this recall.
- Brand
KABOOM- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0296-2016 | LiDa DAIDAIHUA (also packaged as LiDa DAIDAIHUAJIAONANG), capsules, packaged in 1.6oz box 30 capsules per box, Kunming Dali Industry & Trade Co., Ltd; all lots | 25 boxes |
| D-0297-2016 | KABOOM action strips, Sexual Performance Strips, packaged in 6.4oz box 12 strips per box, Nutrology USA LLC; all lots | 132 boxes |
What to do — step by step
Stop using the product
Do not consume the KABOOM action strips or Sexual Performance Strips due to the presence of undeclared Sulfoaildenafil.
Discard the product
Dispose of any remaining boxes to prevent accidental ingestion by others.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0297-2016 (August 6, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0297-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.